The main national and international organisms recommend continuous monitoring of psychological distress in cancer patients throughout the disease trajectory. The reasons for this concern are the high prevalence of psychological distress in cancer patients and its association with a worse quality of life, poor adherence to treatment, and stronger assistance needs. Most screening tools for psychological distress were developed in English-speaking countries. To be fit for use in different cultural contexts (like the Italian), they need to undergo accurate translation and specific validation. In the present work we summarized the validation studies for psychological distress screening tools available in Italian that are most widely employed internationally, with the aim of helping clinicians choose the adequate instrument. With knowledge of the properties of the corresponding Italian versions, researchers would be better able to identify the instruments that deserve further investigation.
Methods
We carried out a systematic review of the literature.
Results
Twenty-nine studies of eight different instruments (five relating to psychological distress, three to its depressive component) were identified. Ten of these studies involved cancer patients and 19 referred to the general population or to non-cancer, non-psychiatric subjects. For seven of the eight tools, data on concurrent and discriminant validity were available. For five instruments data on criterion validity were available, for four there were data on construct validity, and for one tool divergent and cross-cultural validity data were provided. For six of the eight tools the literature provided data on reliability (mostly about internal consistency).
Conclusions
Since none of the eight instruments for which we found validation studies relative to the Italian context had undergone a complete and organic validation process, their use in the clinical context must be cautious. Italian researchers should be proactive and make a valid and reliable screening tool for Italian patients available.
National Comprehensive Cancer Network:Distress management. Clinical practice guidelines.J Natl Compr Canc Netw, 1: 344–374, 2003.
2.
BultzB.D., JohansenC.: Screening for distress, the 6th vital sign: where are we, and where are we going?Psychooncology, 20: 569–571, 2011.
3.
BallengerJ.C., DavidsonJ.R.T., LecrubierY., NuttD.J., JonesR.D., BerardR.M.F.; International Consensus Group on Depression and Anxiety: Consensus statement on depression, anxiety and oncology.J Clin Psychiatry, 62(suppl 8): 64–67, 2001.
4.
GrassiL., NanniM.G., CarusoR.: Emotional distress in cancer: screening policy, clinical limitations and educational needs.Journal of Medicine and the Person, 8: 51–59, 2010.
5.
AnnunziataM.A., MuzzattiB., BidoliE., VeronesiA.: Emotional distress and needs in Italian cancer patients: prevalence and associations with socio-demographic and clinical factors.Tumori, 98: 119–125, 2012.
6.
BultzB.D., CarlsonL.E.: Emotional distress: the sixth vital sign - future directions in cancer care.Psychooncology, 15: 93–95, 2006.
7.
VodermaierA., LindenW., SiuC.: Screening for emotional distress in cancer patients: a systematic review of assessment instruments.J Natl Cancer Inst, 101: 1464–1488, 2009.
8.
BeckA.T., WardC.H., MendelsonM., MockJ., ErbaughJ.: An inventory for measuring depression.Arch Gen Psychiatry, 4: 561–571, 1961.
RadloffL.S.: The CES-D scale: a self-report depression scale for research in the general population.Appl Psych Measure, 1: 385–401, 1977.
11.
AkechiT., OkuyamaT., SugawaraY., ShimaY., FurukawaT.A., UchitomiY.: Screening for depression in terminally ill cancer patients in Japan.J Pain Symptom Manage, 31: 5–12, 2006.
12.
ChochinovH.M., WilsonK.G., EnnsM., LanderS.: “Are you depressed?” Screening for depression in the terminally ill.Am J Psychiatry, 1: 674–676, 1997.
13.
RothA.J., KornblithA.B., Batel-CopelL., PeabodyE., ScherH.I., HollandJ.C.: Rapid screening for psychologic distress in men with prostate carcinoma.Cancer, 82: 1904–1908, 1998.
14.
CoxJ.L., HoldenJ.M., SagovskyR.: Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.Br J Psychiatry, 150: 782–786, 1987.
15.
GoldbergD.: The detection of psychiatric illness by questionnaire.Oxford University Press, London, 1972.
16.
ZigmondA.S., SnaithR.P.: The Hospital Anxiety and Depression Scale.Acta Psychiatr Scand, 67: 361–370, 1983.
17.
StrittmatterG.: Indikation zur Intervention in der Psychoonkologie. Psychosoziale Belastungen und Ermittlung der Betreuungsbedürftigkeit stationärer Hauttumorpatienten. Waxmann, Internationale Hochschulschriften 228, Münster, New York, 1997.
18.
WeathersF.W., FordJ.: Psychometric properties of the PTSD Checklist (PCL-C, PCL-S, PCL-M, PCL-PR). In: Measurement of stress, trauma, and adaptation, StammB.H. (Ed), pp 250–252, Sidran Foundation & Press, Lutherville, MD, 1996.
19.
MorassoG., CostantiniM., BaraccoG., BorreaniC., CapelliM.: Assessing psychological distress in cancer patients: validation of a self-administered questionnaire.Oncology, 53: 295–302, 1996.
20.
LindenW., YiD., BarroetavenaM., MacKenzieR., DollR.: Development and validation of a psychosocial screening instrument for cancer.Health Qual Life Outcomes, 3: 54, 2005.
21.
HerschbachP., Marten-MittagB., HenrichG.: Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23).Z Med Psychol, 12: 1–8, 2003.
22.
de HaesJ.C., van KnippenbergF.C., NeijtJ.P.: Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.Br J Cancer, 62: 1034–1038, 1990.
23.
LuckettT., ButowP.N., KingM.T., OguchiM., HeadingG., HacklN.A., RankinN., PriceM.A.: A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses.Support Care Cancer, 18: 1241–1262, 2010.
24.
MitchellA.J.: Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis.J Natl Comp Canc Netw, 8: 487–494, 2010.
25.
GuilleminF., BombardierC., BeatonD.: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.J Clin Epidemiol, 46: 1417–1432, 1993.
26.
HahnE.A., BodeR.K., DuH., CellaD.: Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial.Clin Trials, 3: 280–290, 2006.
27.
KazdinA.E.: Research design in clinical psychology.Prentice Hall Inc, 1992.
28.
MontanoA., FlebusG.B.: Presentazione del Beck Depression Inventory-Seconda edizione (BDI-II): conferma della struttura bifattoriale in un campione di popolazione italiana.Psicoterap Cogn Comportament, 12: 67–82, 2006.
SicaC., GhisiM.: The Italian versions of the Beck Anxiety Inventory and the Beck Depression Inventory-II: psychometric properties and discriminant power. In: Leading-edge psychological tests and testing research, LangeM.A. (Ed), pp 27–50, Nova Science Publishers, Hauppauge, NY, 2007.
31.
PierfedericiA., FavaG.A., MunariF., RosiN., BaldaroB., Pasquali EvangelistiL., GrandiS., BernardiM., ZecchinoF.: Validazione italiana del CES-D per la misurazione della depressione. In: Nuovi metodi in psicoterapia, CanestrariR. (Ed), pp 95–103, Organizzazioni Speciali, Firenze, 1982.
32.
FavaG.A.: Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale.J Clin Psychol, 39: 249–251, 1983.
33.
CaraccioloB., GiaquintoS.: Criterion validity of the center for epidemiological studies depression (CES-D) scale in a sample of rehabilitation inpatients.J Rehabil Med, 34: 221–225, 2002.
34.
BulliF., MiccinesiG., MaruelliA., KatzM., PaciE.: The measure of psychological distress in cancer patients: the use of Distress Thermometer in the Oncological Rehabilitation Center of Florence.Support Care Cancer, 17: 771–779, 2009.
35.
GrassiL., SabatoS., RossiE., MarmaiL., BiancosinoB.: Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS).J Affect Disord, 114: 193–199, 2009.
36.
GrassiL., MagriV., SabatoS., RossiE.(for the Italian Society of Psycho-Oncology): Screening for distress in cancer patients: the Italian Society of Psycho-Oncology multicenter study on the Distress Thermometer.Psych-Oncol, 19(Suppl 2): 68–69, 2010.
37.
CarpinielloB., ParianteC.M., SerriF., CostaG., CartaM.G.: Validation of the Edinburgh Postnatal Depression Scale in Italy.J Psychosom Obstet Gynaecol, 18: 280–285, 1997.
38.
BenvenutiP., FerraraM., NiccolaiC., ValorianiV., CoxJ.L.: The Edinburgh Postnatal Depression Scale: validation for an Italian sample.J Affect Disord, 53: 137–141, 1999.
39.
FraccaroliF., DepoloM., SarchielliG.: L'uso del General Health Questionnaire di Goldberg in una ricerca su giovani disoccupati.Bollettino di Psicologia Applicata, 197: 13–19, 1991.
40.
FraccaroliF., SchadeeH.M.: L'analisi fattoriale confermativa applicata al General Health Questionnaire. Una comparazione della versione inglese e italiana.GIP, 20: 319–338, 1993.
41.
PiccinelliM., BisoffiG., BonM.G., CunicoL., TansellaM.: Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods.Compr Psychiatry, 34: 198–205, 1993.
42.
PolitiP.L., PiccinelliM., WilkinsonG.: Reliability, validity and factor structure of the 12-item General Health Questionnaire among young males in Italy.Acta Psychiatr Scand, 90: 432–437, 1994.
43.
PicardiA., AbeniD., PasquiniP.: Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12.J Eur Acad Dermatol Venereol, 15: 410–417, 2001.
44.
ClaesR., FraccaroliF.: Il General Health Questionnaire (GHQ-12): invarianza fattoriale in diverse versioni linguistiche.Bollettino di Psicologia Applicata, 237: 25–35, 2002.
45.
PicardiA., AbeniD., MazzottiE., FassoneG., LegaI., RamieriL., SagoniE., TiagoA., PasquiniP.: Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12 item General Health Questionnaire.J Psychosom Res, 57: 219–223, 2004.
46.
PicardiA., AdlerD.A., AbeniD., ChangH., PasquiniP., RogersW.H., BungayK.M.: Screening for depressive disorders in patients with skin diseases: a comparison of three screeners.Acta Derm Venereol, 85: 414–419, 2005.
47.
CostantiniM., MussoM., ViterboriP., BonciF., Del MastroL., GarroneO., VenturiniM., MorassoG.: Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale.Support Care Cancer, 7: 121–127, 1999.
48.
FossatiL., MarzocchiP.: Confronto delle strutture fattoriali dell'Hospital Anxiety and Depression Scale su un campione Italiano di pazienti cardiologici.Giornale di Psicologia, 2: 143–150, 2008.
49.
AnnunziataM.A., MuzzattiB., AltoèG.: Defining Hospital Anxiety and Depression Scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings.Ann Oncol, 22: 2330–2333, 2011.
50.
MondoloF., JahanshahiM., GranàA., BiasuttiE., CacciatoriE., Di BenedettoP.: The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease.Behav Neurol, 17: 109–115, 2006.
51.
CastelliL., BinaschiL., CalderaP., TortaR.: Depression in lung cancer patients: is the HADS an effective screening tool?Support Care Cancer, 17: 1129–1132, 2009.
52.
CastelliL., BinaschiL., CalderaP., MussaA., TortaR.: Fast screening of depression in cancer patients: the effectiveness of the HADS.Eur J Cancer Care, 20: 528–533: 2011.
53.
PaciE.: Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist.Qual Life Res, 1: 129–134, 1992.
54.
RavaioliA., BudaP., FavaC., PaciE., TononiA., RivaN., ZanottiM., DrudiG.: Assessment of the RSCL quality of life instrument during chemotherapy in an Italian setting.Qual Life Res, 5: 491–495, 1996.
55.
BeckA.T., SteerR.A., BrownG.K.: Beck Depression Inventory Second Edition Manual.The Psychological Corporation, San Antonio, TX, 1996.
56.
MitchellA.J., KaarS., CogganC., HerdmanJ.: Acceptability of common screening methods used to detect distress and related mood disorders: preferences of cancer specialists and non-specialists.Psychooncology, 17: 226–236, 2008.
57.
VodermaierA., LindenW.: Emotional distress screening in Canadian cancer care: a survey of utilization, tool choices and practice patterns.Oncol Exchange, 7: 37–40, 2008.
